SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bellicum Pharmaceuticals, Inc. Announces Publication in The New England Journal of Medicine Demonstrating Complete Reversal of Serious Immune Condition in Hematopoietic Stem Cell Transplant Patients